Table: Fuso Pharmaceutical - Q1 parent results

Fuso Pharmaceutical Industries

08/08/2025 07:39

Aug 8 (Reuters)- 
             Fuso Pharmaceutical Industries Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2025        Jun 30, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             15.50               14.62            61.50    
                 (+6.0 pct)          (+8.3 pct)       (+1.5 pct)  
  Operating        596 mln               1.15             3.40    
                 (-48.1 pct)         (+95.1 pct)      (-17.7 pct) 
  Recurring        647 mln             909 mln            3.30    
                 (-28.8 pct)         (+38.2 pct)      (-12.7 pct) 
  Net              462 mln             632 mln            2.30    
                 (-26.9 pct)         (+31.9 pct)                  
  EPS             54.14 yen           74.05 yen       269.24 yen  
  Ann Div                             82.00 yen        90.00 yen  
  -Q2 div                             40.00 yen        45.00 yen  
  -Q4 div                             42.00 yen        45.00 yen  
  
  NOTE - Fuso Pharmaceutical Industries Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4538.T